Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Status:
RECRUITING
Trial end date:
2030-04-01
Target enrollment:
Participant gender:
Summary
Participants in the study will use mifepristone 50 mg once-a-week for one year as a contraceptive. With this, we want to confirm that the chances of getting pregnant while using this contraceptive are very small. We also want to demonstrate that the use of mifepristone is safe, and it does not lead to any severe health problems. We expect fewer side effects compared to other frequently used contraceptives with hormones. Mifepristone does not contain these hormones. It is important to know how people experience that use of one tablet a week.
Phase:
PHASE3
Details
Lead Sponsor:
Leiden University Medical Center
Collaborators:
Children's Investment Fund Foundation Karolinska Institutet Women on Waves